Be a Pioneer – the Freedom to Explore Ion Chromatography

Efficiently manage enzyme assays and measuring conditions for consistent and reliable performance

more

SureSTART autosampler vials for all chromatography applications and budgets

more

Powerful at Every Turn – Meet the NEW General Purpose Centrifuge Family

more

Efficiently manage enzyme assays and measuring conditions for consistent and reliable performance

Precise temperature control and accurate incubation time in seconds eliminates manual errors ✓ Up to 350 tests per hour for a true walk-away solution, fully traceable and audit trailed ✓ Many enzymes, many substratesm many methods – all on a single instrument ✓ more

SureSTART autosampler vials for all chromatography applications and budgets

Sample security and low compound adsorption to keep your samples safe and secure ✓ Three distinct performance levels to meet your price and performance needs ✓ Complete instrument compatibility for all chromatography autosamplers ✓ more

Next-generation cleanroom confidence for cell therapy research and manufacturing

Active particle control system – Certified compatible with ISO Class 5 and GMP Grade A/B ✓ High performance – Active airflow technology, in-chamber HEPA filtration and high heat sterilization ✓ Enhanced cleaning compatibility - IP54 compliant and STERIS compatible ✓ more

LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation

LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Th ... more

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original of ... more

Thermo Fisher Scientific to Acquire QIAGEN

Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to ... more

Learn how breath analysis can detect disease and cancer in its early stage

Breath Biopsy offers a non-invasive and pain free way to monitor human biology and enable the critical early detection of disease more

Clinical research and forensic handbook

Comprehensive collection of information for clinical/translational/drug monitoring research, forensic testing, and sports antidoping analysis more

Delivering on the Promise of the Paperless Lab

Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most comp more

Thermo Fisher Scientific (Schweiz) AG

more

Thermo Fisher Scientific BRAHMS GmbH

more

Thermo Fisher Scientific

Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research ... more